Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: Work of R.B. is supported by the Institutional Strategy of the University of Tübingen (Deutsche Forschungsgemeinschaft, ZUK63).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Deray G, Heurtier A, Grimaldi A, Launay Vacher V, Isnard Bagnis C. Anemia and diabetes. Am J Nephrol 2004;24:522–6.10.1159/000081058Search in Google Scholar PubMed
2. Singh DK, Winocour P, Farrington K. Erythropoietic stress and anemia in diabetes mellitus. Nat Rev Endocrinol 2009;5:204–10.10.1038/nrendo.2009.17Search in Google Scholar PubMed
3. Gauci R, Hunter M, Bruce DG, Davis WA, Davis TM. Anemia complicating type 2 diabetes: prevalence, risk factors and prognosis. J Diabetes Complications 2017;31:1169–74.10.1016/j.jdiacomp.2017.04.002Search in Google Scholar PubMed
4. Lang E, Qadri SM, Lang F. Killing me softly – suicidal erythrocyte death. Int J Biochem Cell Biol 2012;44:1236–43.10.1016/j.biocel.2012.04.019Search in Google Scholar PubMed
5. Pretorius E, du Plooy JN, Bester J. A comprehensive review on eryptosis. Cell Physiol Biochem 2016;39:1977–2000.10.1159/000447895Search in Google Scholar PubMed
6. Lang E, Pozdeev VI, Gatidis S, Qadri SM, Haussinger D, Kubitz R, et al. Bile acid-induced suicidal erythrocyte death. Cell Physiol Biochem 2016;38:1500–9.10.1159/000443091Search in Google Scholar PubMed
7. Bissinger R, Artunc F, Qadri SM, Lang F. Reduced erythrocyte survival in uremic patients under hemodialysis or peritoneal dialysis. Kidney Blood Press Res 2016;41:966–77.10.1159/000452600Search in Google Scholar PubMed
8. Jemaa M, Fezai M, Bissinger R, Lang F. Methods employed in cytofluorometric assessment of eryptosis, the suicidal erythrocyte death. Cell Physiol Biochem 2017; 43:431–44.10.1159/000480469Search in Google Scholar PubMed
9. Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C, et al. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol 2013;50:489–95.10.1007/s00592-011-0274-0Search in Google Scholar PubMed
10. Savu O, Bradescu OM, Serafinceanu C, Iosif L, Tirgoviste CI, Stoian I. Erythrocyte caspase-3 and antioxidant defense is activated in red blood cells and plasma of type 2 diabetes patients at first clinical onset. Redox Rep 2013;18:56–62.10.1179/1351000213Y.0000000040Search in Google Scholar PubMed PubMed Central
©2018 Walter de Gruyter GmbH, Berlin/Boston
